My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 0:54 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. (NPSP.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Pharmaceuticals - Diversified
ยท
View
NPSP
on other exchanges
As of 25 Nov 2009
3.14
USD
Price Change
+0.02
Percent Change
+0.64%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Garceau, Roger
55
2008
Senior Vice President, Chief Medical Officer
Stratemeier, Edward
--
2009
Senior Vice President - Legal Affairs, General Counsel
Nader, Francois
52
2008
President, Chief Executive Officer, Director
Groninger, James
65
1988
Director
Kuhla, Donald
66
1991
Director
Bonney, Michael
50
2005
Director
Selisker, Rachel
53
2005
Director
Broom, Colin
53
2009
Director
Beshar, Luke
50
2007
Chief Financial Officer, Senior Vice President
Tombros, Peter
67
2008
Chairman of the Board
Find out more about NPSP.O
Insider Trading